Bellatora Inc. Announces Name Change, Symbol Change and Reverse Stock Split October 3, 2016 OTC Disclosure & News Service
Bellatora provides a superior suite of innovative vaporizer products and accessories, offering consumers an outlet to make better,
healthier life choices. Bellatora’s purpose is to provide superior and innovative vaporizer products and eLiquids offering tobacco and
marijuana smokers a healthier lifestyle alternative, while not polluting the environment for others. The freedom to vape.
The liberty to enjoy.
An established American marketing, manufacturer, and distributor of electronic vaporizers and e-liquids,
Bellatora displaces big tobacco market share and plays a key role as a delivery system for HEMP PLUS in the emerging marijuana industry.
Bellatora's line up of premium quality electronic cigars, cigarillos and cigarettes provide a non-intrusive and socially friendly alternative
to traditional tobacco and marijuana products.
Vaporizers are devices used to heat up tobacco and marijuana, and release their active ingredients as vapor, rather than smoke.
Vapor use is reported to be a healthier alternative to smoking, as the substances do not have to be combusted, which produce toxic particles in the process.
As a result, many smokers are switching over to vaporizers in order to enjoy their substance of choice,
enjoying a significantly lower risk of harmful health consequences, as well as product discreteness and controlled active ingredient concentration.
Bellatora Inc. is a Colorado Corporation and trades under the symbol ECGR on the Over the Counter US Exchange ECGR-OTCPINK
http://www.otcmarkets.com/stock/ECGR/profile Share Structure Market Value: $39,764,984 / a/o Jan 26, 2017
Shares Outstanding: 40,166,651 a/o Dec 21, 2016
Float: 16,166,651 a/o Jan 03, 2017
Authorized Shares: 200,000,000 a/o Dec 21, 2016
Shareholders of Record: N/A a/o Nov 30, 2016
WAS THIS BELOW/
Outstanding Shares..... 200,800,728
Public Float........... 88,000,728 (+ 112,000,000 Restricted )
Transfer Agent: NONE, handled in-house
Wholly owned subsidiary, Comprehensive Physics and Regulatory Services (CPRS):
William Walker, PhD, CEO of Oncology Med, Inc.